University of Messina-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2023

  1. Diagnosis and management of cardiovascular risk in rheumatoid arthritis: main challenges and research agenda

    Expert Review of Clinical Immunology, Vol. 19, Núm. 3, pp. 279-292

  2. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  3. Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis

    Journal of Clinical Medicine, Vol. 12, Núm. 15

2022

  1. Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice

    Journal of Clinical Medicine, Vol. 11, Núm. 4

2021

  1. Behçet disease: From pathogenesis to novel therapeutic options

    Pharmacological Research, Vol. 167

  2. Cardiovascular effects of approved drugs for rheumatoid arthritis

    Nature Reviews Rheumatology, Vol. 17, Núm. 5, pp. 270-290

  3. Endocan and circulating progenitor cells in women with systemic sclerosis: Association with inflammation and pulmonary hypertension

    Biomedicines, Vol. 9, Núm. 5

  4. Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?

    Frontiers in Medicine, Vol. 8

  5. Publisher Correction: Cardiovascular effects of approved drugs for rheumatoid arthritis (Nature Reviews Rheumatology, (2021), 17, 5, (270-290), 10.1038/s41584-021-00593-3)

    Nature Reviews Rheumatology

  6. The rheumatology drugs for COVID-19 management: Which and when?

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-21

2020

  1. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience

    Journal of Clinical Lipidology, Vol. 14, Núm. 2, pp. 231-240

  2. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1865, Núm. 2

  3. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.

    Progress in Cardiovascular Diseases, Vol. 63, Núm. 3, pp. 327-340

2018

  1. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation

    Atherosclerosis, Vol. 271, pp. 214-222